HIV: an underrecognized secondary cause of osteoporosis? - Wikidata - wikimedia - TriplyDB

HIV: an underrecognized secondary cause of osteoporosis?

HIV: an underrecognized secondary cause of osteoporosis?

http://www.wikidata.org/entity/Q45374537

about

Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.How to predict the risk of fracture in HIV?Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.Bone health and HIV in resource-limited settings: a scoping review.

P2860

Q33361817-06505D96-5DE3-46A9-8E18-110EF5D7B85B Q33588713-55495603-1FC9-430C-8D0E-90CBC69F6CE7 Q38435884-B3C01F0D-5FC0-4712-BE6E-6F22781EE887 Q38792298-58C5D5D6-5424-4F30-B4F6-C1528EF76902

P2860

HIV: an underrecognized secondary cause of osteoporosis?

http://www.wikidata.org/entity/Q45374537

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

HIV: an underrecognized secondary cause of osteoporosis?

@en

HIV: an underrecognized secondary cause of osteoporosis?

@nl

type

label

HIV: an underrecognized secondary cause of osteoporosis?

@en

HIV: an underrecognized secondary cause of osteoporosis?

@nl

prefLabel

HIV: an underrecognized secondary cause of osteoporosis?

@en

HIV: an underrecognized secondary cause of osteoporosis?

@nl

P1433

Q45374537-A1FC34A1-8EEF-49D8-BED3-1CFFDD699CD8

P1476

Q45374537-22DDD2BE-5A4A-4E5E-9CB1-DB85DBDE81B6

P2093

Q45374537-E5EBDD0E-78F4-4F71-AB2F-3E47A221A8C5

P2860

Q45374537-14CC8DBD-0A64-4D92-B1B9-30D30486053F

Q45374537-15B1BF78-4CC9-43A5-8886-E661C81DBAE3

Q45374537-4A76A4BE-23D2-44BB-8869-50746A968F6A

Q45374537-58D1C7E6-374B-434D-A51B-5D2738249A07

Q45374537-61581F98-AB06-4A5A-A733-D257389F0C36

Q45374537-6B379662-C538-410F-B6D3-87904F6A9670

Q45374537-79B0B951-F1CE-4257-8262-1654E5FE8406

Q45374537-A0A6F41F-AC28-4386-87FD-C1E3A3BA4AC3

Q45374537-B8715197-55C4-4EFF-A265-32F67FAF4DD9

Q45374537-CABCB572-99EC-4F44-A620-B15CF012C68A

P304

Q45374537-29F7FD2D-3726-45F4-812F-177D0B41AB09

P31

Q45374537-59962862-4861-430A-B9C4-655F9B0EB96A

P356

Q45374537-250CD21E-72A9-429B-BEBE-904784AA1DB3

P433

Q45374537-0DBDCF1D-0287-418B-9006-4402EC3F516D

P478

Q45374537-13190BD6-DD32-46FA-9870-93C8F3CCCC99

P577

Q45374537-F87BD638-F1DA-463B-84B0-1D9798541029

P5875

Q45374537-3A48C53F-2500-40B5-A9BC-99CAEC70BA72

P698

Q45374537-4F9D6767-578F-4870-A8A0-63FB5C2B883E

P921

Q45374537-57831880-F9B0-4F75-9F1B-C209D8A6DAEB

P356

P1433

Journal of Bone and Mineral Research

P1476

HIV: an underrecognized secondary cause of osteoporosis?

@en

P2093

Todd T Brown

http://www.w3.org/2001/XMLSchema#string

P2860

HIV: inflammation and bone

CD4+ count-guided interruption of antiretroviral treatment

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis.

Continuous antiretroviral therapy decreases bone mineral density.

Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.

P304

1256-1258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.1967

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236581610

http://www.w3.org/2001/XMLSchema#string

P698

23630095

http://www.w3.org/2001/XMLSchema#string

P921